First Patient Dosed in Phase 2 Stroke Trial of ARG-007
Released 27 Mar 24
Latest announcements
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Argenica Therapeutics a question about this announcement.